We Address Unmet Medical Needs to Improve Patient Outcomes and Quality of Life
Abiogen Pharma Completes the Acquisition of Effrx
The product portfolio is led by already commercialized Binosto® for the treatment of postmenopausal osteoporosis.
Partnering with us
Our strategy relies on partnerships for shared commercial success.